{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:54:16Z","timestamp":1791197656056,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,12]]},"DOI":"10.7759\/cureus.26798","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T04:46:20Z","timestamp":1657687580000},"source":"Crossref","is-referenced-by-count":23,"title":["What Role Do Inflammatory Cytokines Play in Cancer Cachexia?"],"prefix":"10.7759","author":[{"given":"Jyothirmai","family":"Malla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharun Yadhav","family":"Selvamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoukrie I","family":"Shoukrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramaneshwar","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravneet K","family":"Dhanoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranim K","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihan","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. World Health Organization, Geneva; 2020."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729182","article-title":"Activation of the adipose tissue NLRP3 inflammasome pathway in cancer cachexia","volume":"12","author":"de Jesus JC","year":"2021","unstructured":"de Jesus JC, Murari AS, Radloff K, et al.. Activation of the adipose tissue NLRP3 inflammasome pathway in cancer cachexia. Front Immunol. 2021, 12:729182. 10.3389\/fimmu.2021.729182","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123527","article-title":"Decreased miR-497-5p suppresses IL-6 induced atrophy in muscle cells","volume":"10","author":"Freire PP","year":"2021","unstructured":"Freire PP, Cury SS, Lopes LO, et al.. Decreased miR-497-5p suppresses IL-6 induced atrophy in muscle cells. Cells. 2021, 10:3527. 10.3390\/cells10123527","journal-title":"Cells"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/nu7064465","article-title":"NF-\u03baBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients","volume":"7","author":"Camargo RG","year":"2015","unstructured":"Camargo RG, Riccardi DM, Ribeiro HQ, et al.. NF-\u03baBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients. Nutrients. 2015, 7:4465-79. 10.3390\/nu7064465","journal-title":"Nutrients"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0017-7","article-title":"l-carnitine and cancer cachexia: clinical and experimental aspects","volume":"2","author":"Silv\u00e9rio R","year":"2011","unstructured":"Silv\u00e9rio R, Laviano A, Rossi Fanelli F, Seelaender M. l-carnitine and cancer cachexia: clinical and experimental aspects. J Cachexia Sarcopenia Muscle. 2011, 2:37-44. 10.1007\/s13539-011-0017-7","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref6","article-title":"Current perspectives of catabolic mediators of cancer cachexia","volume":"13","author":"Lelbach A","year":"2007","unstructured":"Lelbach A, Muzes G, Feher J. Current perspectives of catabolic mediators of cancer cachexia. Med Sci Monit. 2007, 13:RA168-173.","journal-title":"Med Sci Monit"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3178-8","article-title":"Adipose tissue fibrosis in human cancer cachexia: the role of TGF\u03b2 pathway","volume":"17","author":"Alves MJ","year":"2017","unstructured":"Alves MJ, Figuer\u00eado RG, Azevedo FF, et al.. Adipose tissue fibrosis in human cancer cachexia: the role of TGF\u03b2 pathway. BMC Cancer. 2017, 17:190. 10.1186\/s12885-017-3178-8","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12909","article-title":"C\/EBP\u03b2 promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia","volume":"13","author":"AlSudais H","year":"2022","unstructured":"AlSudais H, Rajgara R, Saleh A, Wiper-Bergeron N. C\/EBP\u03b2 promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia. J Cachexia Sarcopenia Muscle. 2022, 13:743-57. 10.1002\/jcsm.12909","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i31.4383","article-title":"Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance","volume":"25","author":"Tuomisto AE","year":"2019","unstructured":"Tuomisto AE, M\u00e4kinen MJ, V\u00e4yrynen JP. Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019, 25:4383-404. 10.3748\/wjg.v25.i31.4383","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon K","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al.. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011, 12:489-95. 10.1016\/S1470-2045(10)70218-7","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and skeletal muscle wasting during cachexia","volume":"11","author":"Webster JM","year":"2020","unstructured":"Webster JM, Kempen LJ, Hardy RS, Langen RC. Inflammation and skeletal muscle wasting during cachexia. Front Physiol. 2020, 11:597675. 10.3389\/fphys.2020.597675","journal-title":"Front Physiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12627","article-title":"Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia","volume":"11","author":"Vaes RD","year":"2020","unstructured":"Vaes RD, van Dijk DP, Welbers TT, et al.. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia. J Cachexia Sarcopenia Muscle. 2020, 11:1509-24. 10.1002\/jcsm.12627","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00408.2001","article-title":"Proteolysis-inducing factor differentially influences transcriptional regulation in endothelial subtypes","volume":"282","author":"Watchorn TM","year":"2002","unstructured":"Watchorn TM, Waddell I, Ross JA. Proteolysis-inducing factor differentially influences transcriptional regulation in endothelial subtypes. Am J Physiol Endocrinol Metab. 2002, 282:E763-9. 10.1152\/ajpendo.00408.2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12345","article-title":"Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients","volume":"9","author":"Neto NI","year":"2018","unstructured":"Neto NI, Murari AS, Oyama LM, et al.. Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients. J Cachexia Sarcopenia Muscle. 2018, 9:1101-8. 10.1002\/jcsm.12345","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner L","year":"2015","unstructured":"Lerner L, Hayes TG, Tao N, et al.. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J Cachexia Sarcopenia Muscle. 2015, 6:317-24. 10.1002\/jcsm.12033","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27269","article-title":"Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients","volume":"10","author":"Neto NI","year":"2019","unstructured":"Neto NI, Boldarine VT, Hachul AC, et al.. Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients. Oncotarget. 2019, 10:6444-55. 10.18632\/oncotarget.27269","journal-title":"Oncotarget"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0054-2","article-title":"Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle","volume":"24","author":"Wang G","year":"2018","unstructured":"Wang G, Biswas AK, Ma W, et al.. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat Med. 2018, 24:770-81. 10.1038\/s41591-018-0054-2","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/j.pbj.0000000000000123","article-title":"Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia","volume":"6","author":"Tavares P","year":"2021","unstructured":"Tavares P, Gon\u00e7alves DM, Santos LL, Ferreira R. Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia. Porto Biomed J. 2021, 6:e123. 10.1097\/j.pbj.0000000000000123","journal-title":"Porto Biomed J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2197-2","article-title":"Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6","volume":"5","author":"Beliz\u00e1rio JE","year":"2016","unstructured":"Beliz\u00e1rio JE, Fontes-Oliveira CC, Borges JP, Kashiabara JA, Vannier E. Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6. Springerplus. 2016, 5:619. 10.1186\/s40064-016-2197-2","journal-title":"Springerplus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082299","article-title":"Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment","volume":"19","author":"Kasembeli MM","year":"2018","unstructured":"Kasembeli MM, Bharadwaj U, Robinson P, Tweardy DJ. Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment. Int J Mol Sci. 2018, 19:2299. 10.3390\/ijms19082299","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2102","article-title":"Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia","volume":"64","author":"Kwak KS","year":"2004","unstructured":"Kwak KS, Zhou X, Solomon V, et al.. Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia. Cancer Res. 2004, 64:8193-8. 10.1158\/0008-5472.CAN-04-2102","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12320","article-title":"Pharmacology of manipulating lean body mass","volume":"42","author":"Sepulveda PV","year":"2015","unstructured":"Sepulveda PV, Bush ED, Baar K. Pharmacology of manipulating lean body mass. Clin Exp Pharmacol Physiol. 2015, 42:1-13. 10.1111\/1440-1681.12320","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3292087","article-title":"Disrupted skeletal muscle mitochondrial dynamics, mitophagy, and biogenesis during cancer cachexia: a role for inflammation","volume":"2017","author":"VanderVeen BN","year":"2017","unstructured":"VanderVeen BN, Fix DK, Carson JA. Disrupted skeletal muscle mitochondrial dynamics, mitophagy, and biogenesis during cancer cachexia: a role for inflammation. Oxid Med Cell Longev. 2017, 2017:3292087. 10.1155\/2017\/3292087","journal-title":"Oxid Med Cell Longev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100358","article-title":"Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia","volume":"3","author":"Hall DT","year":"2011","unstructured":"Hall DT, Ma JF, Marco SD, Gallouzi IE. Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia. Aging (Albany NY). 2011, 3:702-15. 10.18632\/aging.100358","journal-title":"Aging (Albany NY)"},{"key":"ref25","article-title":"Comparison of cachectic and non-cachectic sarcoma patients reveals an important role of Notch signaling in metastasis and myogenesis","volume":"9","author":"Lu F","year":"2019","unstructured":"Lu F, Osei-Hwedieh D, Mandell JB, et al.. Comparison of cachectic and non-cachectic sarcoma patients reveals an important role of Notch signaling in metastasis and myogenesis. Am J Cancer Res. 2019, 9:1746-56.","journal-title":"Am J Cancer Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133285","article-title":"Control of skeletal muscle atrophy associated to cancer or corticosteroids by ceramide kinase","volume":"13","author":"Pierucci F","year":"2021","unstructured":"Pierucci F, Frati A, Battistini C, Penna F, Costelli P, Meacci E. Control of skeletal muscle atrophy associated to cancer or corticosteroids by ceramide kinase. Cancers (Basel). 2021, 13:3285. 10.3390\/cancers13133285","journal-title":"Cancers (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071816","article-title":"Sustained systemic levels of IL-6 impinge early muscle growth and induce muscle atrophy and wasting in adulthood","volume":"10","author":"Pelosi L","year":"2021","unstructured":"Pelosi L, Berardinelli MG, Forcina L, et al.. Sustained systemic levels of IL-6 impinge early muscle growth and induce muscle atrophy and wasting in adulthood. Cells. 2021, 10:1816. 10.3390\/cells10071816","journal-title":"Cells"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00004","article-title":"Plasma lipid profile and systemic inflammation in patients with cancer cachexia","volume":"7","author":"Riccardi DM","year":"2020","unstructured":"Riccardi DM, das Neves RX, de Matos-Neto EM, et al.. Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Front Nutr. 2020, 7:4. 10.3389\/fnut.2020.00004","journal-title":"Front Nutr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0018","article-title":"Anorexia-cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma","volume":"2017","author":"Balc\u00e1zar-Hern\u00e1ndez L","year":"2017","unstructured":"Balc\u00e1zar-Hern\u00e1ndez L, Vargas-Ortega G, Valverde-Garc\u00eda Y, Mendoza-Zubieta V, Gonz\u00e1lez-Virla B. Anorexia-cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma. Endocrinol Diabetes Metab Case Rep. 2017, 2017:17-0018. 10.1530\/EDM-17-0018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12449","article-title":"Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa","volume":"10","author":"Costa RG","year":"2019","unstructured":"Costa RG, Caro PL, de Matos-Neto EM, et al.. Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa. J Cachexia Sarcopenia Muscle. 2019, 10:1116-27. 10.1002\/jcsm.12449","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.07.012","article-title":"Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E)","volume":"380","author":"Husain A","year":"2016","unstructured":"Husain A, Hu N, Sadow PM, Nucera C. Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E). Cancer Lett. 2016, 380:577-85. 10.1016\/j.canlet.2015.07.012","journal-title":"Cancer Lett"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/1179554917690144","article-title":"Effects of serum leptin and resistin levels on cancer cachexia in patients with advanced-stage non-small cell lung cancer","volume":"11","author":"Demiray G","year":"2017","unstructured":"Demiray G, De\u011firmencio\u011flu S, U\u011furlu E, Yaren A. Effects of serum leptin and resistin levels on cancer cachexia in patients with advanced-stage non-small cell lung cancer. Clin Med Insights Oncol. 2017, 11:1179554917690144. 10.1177\/1179554917690144","journal-title":"Clin Med Insights Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.21037\/apm.2018.07.06","article-title":"Anti-cytokines in the treatment of cancer cachexia","volume":"8","author":"Prado BL","year":"2019","unstructured":"Prado BL, Qian Y. Anti-cytokines in the treatment of cancer cachexia. Ann Palliat Med. 2019, 8:67-79. 10.21037\/apm.2018.07.06","journal-title":"Ann Palliat Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061543","article-title":"Pancreatic cancer and cachexia-metabolic mechanisms and novel insights","volume":"12","author":"Poulia KA","year":"2020","unstructured":"Poulia KA, Sarantis P, Antoniadou D, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV. Pancreatic cancer and cachexia-metabolic mechanisms and novel insights. Nutrients. 2020, 12:1543. 10.3390\/nu12061543","journal-title":"Nutrients"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexia--pathophysiology and management","volume":"48","author":"Suzuki H","year":"2013","unstructured":"Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Cancer cachexia--pathophysiology and management. J Gastroenterol. 2013, 48:574-94. 10.1007\/s00535-013-0787-0","journal-title":"J Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial","volume":"54","author":"Gordon JN","year":"2005","unstructured":"Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut. 2005, 54:540-5. 10.1136\/gut.2004.047563","journal-title":"Gut"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1159\/000346446","article-title":"Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide","volume":"58","author":"Wen HS","year":"2012","unstructured":"Wen HS, Li X, Cao YZ, Zhang CC, Yang F, Shi YM, Peng LM. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide. Chemotherapy. 2012, 58:461-7. 10.1159\/000346446","journal-title":"Chemotherapy"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18244-8","article-title":"IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models","volume":"11","author":"Lu SW","year":"2020","unstructured":"Lu SW, Pan HC, Hsu YH, Chang KC, Wu LW, Chen WY, Chang MS. IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models. Nat Commun. 2020, 11:4611. 10.1038\/s41467-020-18244-8","journal-title":"Nat Commun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/91540-what-role-do-inflammatory-cytokines-play-in-cancer-cachexia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:51Z","timestamp":1707507531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/91540-what-role-do-inflammatory-cytokines-play-in-cancer-cachexia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.26798","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,12]]}}}